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Erythema multiforme (EM) is an acute, self-limited, some-
times recurring mucocutaneous condition characterized by
distinctive target lesions, and it has been associated with
infections, accounting for up to 90% of cases, as well as
with drugs, and other triggers.1 Most cases of EM occur in
children, adolescents, and young adults,1 but rarely occur
in neonates and infants.2 Here, we report three infants in
whom EM developed following hepatitis B vaccination.2. Case series
Three male infants were admitted over the past 2 years
with EM following hepatitis B vaccination. They were born
at full-term gestation and had a mean age of 37 days at
presentation. All had the main complaints of rash with
preceding hepatitis B vaccination administered 1e5 days
earlier, and fever beginning on the day of presentation,
with no localizing symptoms or risk factors for infection. On
examination, they had raised targetoid lesions over the
face, chest, abdomen, and limbs. Figures S1 and S2 depict
the targetoid rash in the first two infants.* Corresponding author. Department of Paediatrics, KK Women’s
and Children’s Hospital, Children’s Tower Level 4, 100 Bukit Timah
Road, 229899, Singapore.
E-mail address: tanzhenhan@gmail.com (Z.H. Tan).
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CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-ndA full sepsis work-up was performed in each infant. The
fever settled within 1 day of admission in all of the infants,
and was attributed to postvaccination fever, with negative
microbiological investigations. The skin rash was clinically
diagnosed by the dermatologist as EM secondary to hepa-
titis B vaccination, in view of the temporal relationship
between the development of EM and the vaccination, and
in the absence of other known causes of EM. No skin bi-
opsies were performed. The rash lasted for a mean duration
of 2 weeks. There were no recurrences of EM in two of the
infants, with a follow-up appointment being scheduled for
the third infant. Table 1 summarizes the patient charac-
teristics and investigation results of the three infants.
3. Discussion
Although the pathophysiology of EM is still not completely
understood, it is in part due to a type IV hypersensitivity
reaction that can be triggered by numerous factors,
including infections (for which the most common organisms
are herpes simplex virus types 1 and 2 and mycoplasma
pneumoniae), as well as drugs such as nonsteroidal anti-
inflammatory drugs, antiepileptics, and antibiotics.1 Vac-
cinations have also been implicated in EM. In particular,
there have been several adult cases of EM following hepa-
titis B vaccination, as well as a similar case in a 1-month-old
infant.3,4 It is speculated that the hepatitis B surface an-
tigen (HBsAg) may be responsible for the reaction,3,4 where
specific immune stimulation postvaccination can induce the
formation of immune complexes as well as stimulation of Tby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Table 1 Characteristics of the three patients with erythema multiforme.
Patient
No.
Age
(d)
Gender Rash Characteristics
of rash
Other
presenting
symptom(s)
on
admission
Interval
between
hepatitis B
vaccination
& onset of
rash (d)
Reactions to
previous
vaccinations
Clinical or
histopathological
diagnosis of
erythema
multiforme (EM)
Investigation
results
Treatment Duration of
hospitalization
(d)
Duration
of
rash
before
complete
resolution
(wk)
Recurrence of EM
1 35 Male Rash
for 3
d
Raised targetoid
lesions over face,
chest, abdomen
& limbs
Lesions remained
fixed over 24
hours
No blistering or
necrosis
No mucosal
involvement,
angioedema, or
dermatographism
Fever of up
to
38.3C for 1
d
1 Nil Bacillus
Calmette-
Guerin & 1st
dose of
hepatitis B
vaccinations
were given
at birth with
no issues
Clinical diagnosis
of EM made by
dermatologist
Blood investigations
(1) Haemoglobin (Hb)
12.7 g/DL (normal
range 9e14 g/DL),
white blood cell
count (WBC)
8.43  109/L (normal
range 5e15  109/L),
platelet count
414  109/L (normal
range 150
e450  109 L)
(2) C-reactive protein
(CRP) 20.5 mg/L
(normal range 0
e5 mg/L)
(3) Liver function test
normal
Microbiological
investigations
(1) Blood, urine & cere-
brospinal (CSF) bac-
terial cultures
negative
(2) Throat swab & CSF
for enterovirus (EV)
PCR negative
(3) CSF for herpes sim-
plex virus (HSV) PCR
negative
(4) Throat swab for my-
coplasma pneumo-
niae PCR negative
(5) Nasopharyngeal aspi-
rate for respiratory
viruses antigen
negative
Full sepsis
work-up
performed
&
empirical
Ampicillin &
Gentamicin
started
Topical
Desonide
0.05% for
rash
3 2 No recurrence of EM,
even with his 3rd dose
of hepatitis B
vaccination
at 6 mo of age & other
vaccinations (rotavirus,
pneumococcal, &
combined
diphtheria,
tetanus,polio,
pertussis & haemophilus
influenzae type b
[(DTaP/IPV/Hib)]
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Table 1 (continued )
Patient
No.
Age
(d)
Gender Rash Characteristics
of rash
Other
presenting
symptom(s)
on
admission
Interval
between
hepatitis B
vaccination
& onset of
rash (d)
Reactions to
previous
vaccinations
Clinical or
histopathological
diagnosis of
erythema
multiforme (EM)
Investigation
results
Treatment Duration of
hospitalization
(d)
Duration
of
rash
before
complete
resolution
(wk)
Recurrence of EM
2 37 Male Rash
for
1 d
Raised targetoid
lesions over face,
chest, abdomen
& limbs
Lesions remained
fixed over 24
hours
No blistering or
necrosis
No mucosal
involvement,
angioedema, or
dermatographism
Fever of up
to
38C for 1 d
5 Nil
Bacillus
Calmette-
Guerin & 1st
dose
of hepatitis
B
vaccinations
were
given at
birth with no
issues
Clinical diagnosis
of EM made by
dermatologist
Blood investigations
(1) Hb 10.7 g/DL, WBC
12.59  109/ L,
platelet count
508  109/L
(2) CRP 9.7 mg/L
Microbiological
investigations
(1) Blood, urine & CSF
bacterial cultures
negative
(2) Throat swab & CSF
for EV & HSV PCR
negative
(3) Urine for cytomega-
lovirus PCR negative
Full sepsis
work-up
performed
&
empirical
Ampicillin &
Gentamicin
started
Topical
aqueous
cream
for rash
4 3 No recurrence
Defaulted the follow-up
at 6 mo of age as he had
moved overseas
Subsequent telephone
conversion with his
grandparents revealed
that he had received 3
more vaccinations with
no recurrence of EM
3 40 Male Rash
for 2
d
Raised targetoid
lesions over face,
chest, abdomen
& limbs
Lesions remained
fixed over 24
hours No
blistering or
necrosis No
mucosal
involvement,
angioedema, or
dermatographism
Fever of up
to
38.5C for 1
d
5 Nil
Bacillus
Calmette-
Guerin & 1st
dose of
hepatitis B
vaccinations
were given
at birth with
no issues
Clinical diagnosis
of EM made by
dermatologist
Blood investigations
(1) Hb 10.3g/DL, WBC
17.58  109/L (neu-
trophils 39%, lym-
phocytes 55%.
monocytes 5%),
platelet count
667  109/L
(2) CRP 9.2 mg/L
(3) Liver function test
normal
Microbiological
investigations
(1) Blood, urine & CSF
bacterial cultures
negative
(2) CSF for EV & HSV PCR
negative
Full sepsis
work-up
performed
&
empirical
Ampicillin &
Gentamicin
started
3 1 Follow-up appointment
scheduled
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Erythema multiforme following hepatitis B vaccination 75lymphocytes, which can then react with peptides shared by
HBsAg and keratinocytes.4 The lack of reaction with the
subsequent vaccination dose could be attributed to immune
maturation.3
Other possible differentials include urticaria multi-
forme, where annular wheals with an ecchymotic center
may be present, but these lesions typically last for
<24 hours, are pruritic, and are associated with derma-
tographism and facial or acral edema.5 Acute hemorrhagic
edema of infancy is a distinctive leukocytoclastic vasculitis
affecting infants younger than 6 months, often following a
viral infection and presentation is often dramatic, with
large targetoid purpuric lesions localized to the cheeks,
ears, and acral regions, and facial and limb edema is often
present.6
Diagnosis of erythema multiforme is usually clinical, but
skin biopsy can help confirm the diagnosis.1,6 Histology
typically shows a lymphohistiocytic infiltrate along the
dermoepidermal junction and surrounding blood vessels,
basal epidermal cell vacuolar degeneration, scattered
necrotic keratinocytes, and lymphocyte exocytosis.1 Sub-
epidermal clefting and vesiculation may occur due to
extensive basal cell vacuolar degeneration.1
Management of EM is largely symptomatic, and topical
low potency corticosteroids may be helpful.1,6 Parents
should be reassured that EM following immunization is not a
contraindication for subsequent doses of the same vaccine.
Although active monitoring during the subsequent doses
may be considered, no specific measures may be needed,
given that no recurrence occurred in two of our cases. In an
Australian study of 421 children with a history of an adverse
event following immunization (AEFI), 33 children had a skin
rash following immunization, and none had a recurrence
following re-immunization.7
4. Conclusion
These three cases highlight a possible temporal association
between EM and hepatitis B vaccination, although there
was no evidence of causation. Clinicians who vaccinate
children on a regular basis should be aware of this poten-
tially rare AEFI, as this may help avoid unnecessaryinvestigations in evaluating the etiology of EM. Parents
should be reassured that EM following immunization is not a
contraindication for continuing the vaccination course, and
that the benefits of vaccination outweigh its risks.
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